Quantifying the pharmacology of antimalarial drug combination therapy.
about
New developments in anti-malarial target candidate and product profilespfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies.Split dosing of artemisinins does not improve antimalarial therapeutic efficacyPlasmodium falciparum Plasmepsin 2 Duplications, West Africa
P2860
Quantifying the pharmacology of antimalarial drug combination therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantifying the pharmacology of antimalarial drug combination therapy.
@en
Quantifying the pharmacology of antimalarial drug combination therapy.
@nl
type
label
Quantifying the pharmacology of antimalarial drug combination therapy.
@en
Quantifying the pharmacology of antimalarial drug combination therapy.
@nl
prefLabel
Quantifying the pharmacology of antimalarial drug combination therapy.
@en
Quantifying the pharmacology of antimalarial drug combination therapy.
@nl
P2860
P356
P1433
P1476
Quantifying the pharmacology of antimalarial drug combination therapy
@en
P2093
Eva Maria Hodel
P2860
P2888
P356
10.1038/SREP32762
P407
P577
2016-09-08T00:00:00Z